PFMT Stock Forecast 2025-2026
Distance to PFMT Price Targets
PFMT Price Momentum
🤔 Considering Performant Financial (PFMT)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Latest PFMT Stock Price Targets & Analyst Predictions
Based on our analysis of 4 Wall Street analysts, PFMT has a bullish consensus with a median price target of $7.00 (ranging from $6.00 to $8.00). Currently trading at $2.90, the median forecast implies a 141.4% upside. This outlook is supported by 3 Buy, 0 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Kyle Bauser at B. Riley Securities, projecting a 175.9% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
PFMT Analyst Ratings
PFMT Price Target Range
Latest PFMT Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for PFMT.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Nov 7, 2024 | B. Riley Securities | Kyle Bauser | Buy | Maintains | $7.00 |
| Jul 25, 2024 | B. Riley Securities | Kyle Bauser | Buy | Initiates | $8.00 |
| Dec 20, 2022 | Lake Street | Jacob Stephan | Buy | Assumes | $8.00 |
| Jul 7, 2021 | Craig-Hallum | George Sutton | Buy | Initiates | $10.00 |
| Jun 4, 2021 | Colliers Securities | Buy | Initiates | $0.00 | |
| Jan 12, 2018 | Compass Point | Buy | Upgrade | $0.00 | |
| Dec 12, 2016 | Compass Point | Neutral | Downgrade | $0.00 | |
| Feb 27, 2015 | Compass Point | Neutral | Downgrade | $0.00 | |
| Nov 25, 2014 | Macquarie | Neutral | Initiates | $0.00 | |
| Nov 10, 2014 | Morgan Stanley | Equal-Weight | Downgrade | $9.00 | |
| Nov 7, 2014 | William Blair | Market Perform | Downgrade | $0.00 | |
| Oct 8, 2014 | Compass Point | Buy | Maintains | $11.00 | |
| Jun 12, 2014 | SunTrust Robinson Humphrey | Buy | Maintains | $0.00 | |
| Jun 11, 2014 | SunTrust Robinson Humphrey | Buy | Maintains | $11.75 | |
| Feb 28, 2014 | Compass Point | Buy | Maintains | $11.00 | |
| Feb 28, 2014 | Credit Suisse | Neutral | Downgrade | $8.00 | |
| Feb 28, 2014 | SunTrust Robinson Humphrey | Buy | Upgrade | $10.00 | |
| Feb 28, 2014 | Morgan Stanley | Overweight | Maintains | $12.00 | |
| Feb 21, 2014 | Wells Fargo | Market Perform | Downgrade | $0.00 | |
| Jan 21, 2014 | Compass Point | Buy | Maintains | $13.00 |
Performant Healthcare Inc. (PFMT) Competitors
The following stocks are similar to Performant Financial based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Performant Healthcare Inc. (PFMT) Financial Data
Performant Healthcare Inc. has a market capitalization of $278.72M with a P/E ratio of -29.0x. The company generates $120.78M in trailing twelve-month revenue with a -6.7% profit margin.
Revenue growth is +5.2% quarter-over-quarter, while maintaining an operating margin of -6.8% and return on equity of -10.6%.
Valuation Metrics
Growth & Margins
Financial Health
🔥 Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.
Performant Healthcare Inc. (PFMT) Business Model
About Performant Healthcare Inc.
Provides payment integrity and eligibility services.
Performant Healthcare Inc. generates revenue by offering payment integrity, audit, recovery, and consulting services to healthcare payers and providers. The company helps clients identify and rectify improper payments, thereby optimizing their revenue cycles and enhancing operational efficiency.
The company focuses on technology-driven solutions that modernize healthcare financial management, particularly impacting the Medicaid, Medicare, and commercial insurance sectors. By providing actionable insights and comprehensive managed services, Performant aims to improve clients' payment and billing processes, allowing them to prioritize patient care and quality improvement.
Company Information
Sector
Healthcare
Industry
Health Information Services
Employees
958
CEO
Mr. Simeon M. Kohl
Country
United States
IPO Year
2012
Website
performantcorp.comPerformant Healthcare Inc. (PFMT) Latest News & Analysis
Performant Healthcare, Inc. will change its Nasdaq ticker symbol from "PFMT" to "PHLT" on December 18, 2024, reflecting its focus on healthcare payment integrity solutions.
The ticker change to "PHLT" signals Performant's focus on healthcare payment integrity, potentially attracting investors interested in the growing healthcare sector.
Performant Announces Name Change to Performant Healthcare, Inc. – Concludes Strategic Shift to Healthcare
3 months agoPerformant Financial Corporation has rebranded to Performant Healthcare, Inc. and will update its ticker symbol to PHLT. This change does not affect its operations or management.
The name change to Performant Healthcare and new ticker symbol PHLT signal a strategic focus on healthcare services, potentially attracting investors interested in the growing health tech sector.
Performant to Participate in the Noble Capital Markets 20th Annual Emerging Growth Equity Conference
3 months agoPerformant Financial Corporation (Nasdaq: PFMT) will present at the Noble Capital Markets Emerging Growth Equity Conference on December 3, discussing updates including New York State Medicaid developments.
Performant Financial's participation in a prominent conference signals potential growth opportunities and increased visibility, which could positively influence investor sentiment and stock performance.
Performant Financial's Q3/2024 results met expectations, but reduced customer care services may affect revenue. Management maintains full-year profitability and core healthcare revenue projections, facing challenges from the election cycle and a cybersecurity breach.
Performant Financial's Q3 results align with expectations, but reduced customer care may hinder growth. Stability in profitability projections amid challenges could influence investor confidence.
Performant Financial Corporation (Nasdaq: PFMT) will attend the 15th Annual Craig-Hallum Alpha Select Conference in NYC on November 19th, with CEO Simeon Kohl and CFO Rohit Ramchandani meeting investors.
Performant Financial's participation in the conference signals potential growth insights and strategic updates, which could influence investor sentiment and stock performance.
Performant Financial Corporation (PFMT) held its Q3 2024 earnings call, details of which may provide insights into the company's financial performance and future outlook.
The Q3 2024 earnings call for Performant Financial Corporation provides insights into financial performance, growth prospects, and strategic direction, impacting stock valuation and investor sentiment.
Frequently Asked Questions About PFMT Stock
What is Performant Healthcare Inc.'s (PFMT) stock forecast for 2025?
Based on our analysis of 4 Wall Street analysts, Performant Healthcare Inc. (PFMT) has a median price target of $7.00. The highest price target is $8.00 and the lowest is $6.00.
Is PFMT stock a good investment in 2025?
According to current analyst ratings, PFMT has 3 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $2.90. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for PFMT stock?
Wall Street analysts predict PFMT stock could reach $7.00 in the next 12 months. This represents a 141.4% increase from the current price of $2.90. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Performant Healthcare Inc.'s business model?
Performant Healthcare Inc. generates revenue by offering payment integrity, audit, recovery, and consulting services to healthcare payers and providers. The company helps clients identify and rectify improper payments, thereby optimizing their revenue cycles and enhancing operational efficiency.
What is the highest forecasted price for PFMT Performant Healthcare Inc.?
The highest price target for PFMT is $8.00 from Kyle Bauser at B. Riley Securities, which represents a 175.9% increase from the current price of $2.90.
What is the lowest forecasted price for PFMT Performant Healthcare Inc.?
The lowest price target for PFMT is $6.00 from at , which represents a 106.9% increase from the current price of $2.90.
What is the overall PFMT consensus from analysts for Performant Healthcare Inc.?
The overall analyst consensus for PFMT is bullish. Out of 4 Wall Street analysts, 3 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $7.00.
How accurate are PFMT stock price projections?
Stock price projections, including those for Performant Healthcare Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
